MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0002499
Insys Pharmaceuticals Private Limited
Insys Pharmaceuticals Private Limited - business services in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹17.8 Lakh
▲ 43% YoY
Net profit · FY 2024
₹24,037
Net margin 1.4%
EBITDA · FY 2024
₹47,622
EBITDA margin 2.7%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered
About Insys Pharmaceuticals Private Limited
Data last updated:
Insys Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 23 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC314945. Its GSTIN is 07AAECI4369P2ZW (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Shailendra Singh and Sangeeta Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 5 Block – D Ground Floor Kh No – 687/689 Jaitpur Extension – II, New Delhi, Delhi, India – 110044.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.8 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹24,037 (net margin 1.4%) and EBITDA of ₹47,622 (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 55% over three years and 10% over five years.
Insys Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0002499). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999DL2017PTC314945
Registration Number 314945
Incorporation Date 23 March 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0002499
Recognitions & Rankings of Insys Pharmaceuticals
Contact details
Insys Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressB – 5 Block – D Ground Floor Kh No – 687/689 Jaitpur Extension – II, New Delhi, Delhi, India – 110044
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Insys Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Insys Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Insys Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Insys Pharmaceuticals Private Limited, buy the company report.
Financials of Insys Pharmaceuticals Private Limited
FY 2025 filings availableInsys Pharmaceuticals Private Limited reported revenue of ₹17.8 Lakh (up 43% YoY) for FY 2024.
Revenue · FY 2024
₹17.8 Lakh ▲ 43%
Net profit · FY 2024
₹24,037 margin 1.4%
EBITDA · FY 2024
₹47,622 margin 2.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 55%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 25%
5 years · compounded
▲ 43%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 43% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹47,622 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24,037 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Insys Pharmaceuticals Private Limited, buy the company report.
Board of directors of Insys Pharmaceuticals Private Limited
Insys Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailendra Singh | Director | 23 Mar 2017 | 9 Years 7 Months | Current |
| Sangeeta Kumari | Director | 12 Jun 2018 | 8 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Insys Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Insys Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Insys Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECI4369P2ZW | Delhi | Active | 24 Jan 2018 |
To see the full GST registrations and return filing status of Insys Pharmaceuticals Private Limited, buy the company report.
Recent activity
Insys Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Moti Lal ceased to be Director on 13 Jun 2018.
AGM
Insys Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Insys Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Moti Lal ceased to be Director.
Appointed
Sangeeta Kumari was appointed as Director.
Appointed
Shailendra Singh was appointed as Director.
Incorporation
23 Mar 2017
Insys Pharmaceuticals Private Limited was registered on 23 Mar 2017 with Roc Delhi & aged 9 years 7 months as per MCA records.
Frequently asked questions
Insys Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 23 March 2017 (9+ years old) and is registered under CIN U74999DL2017PTC314945.
Insys Pharmaceuticals has 2 current directors:
- Shailendra Singh - Director
- Sangeeta Kumari - Director
The latest financial statements of Insys Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Insys Pharmaceuticals is 07AAECI4369P2ZW, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Insys Pharmaceuticals is U74999DL2017PTC314945. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Insys Pharmaceuticals was incorporated on 23 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Moti Lal ceased to be Director on 13 Jun 2018. Sangeeta Kumari was appointed as Director on 12 Jun 2018. Shailendra Singh was appointed as Director on 23 Mar 2017.
Yes, Insys Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0002499).
The registered office of Insys Pharmaceuticals is at B – 5 Block – D Ground Floor Kh No – 687689 Jaitpur Extension – II, New Delhi, Delhi, India – 110044.
Insys Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.